181 related articles for article (PubMed ID: 26724290)
1. Norepinephrine Dosing in Obese and Nonobese Patients With Septic Shock.
Radosevich JJ; Patanwala AE; Erstad BL
Am J Crit Care; 2016 Jan; 25(1):27-32. PubMed ID: 26724290
[TBL] [Abstract][Full Text] [Related]
2. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
Vadiei N; Daley MJ; Murthy MS; Shuman CS
Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
[TBL] [Abstract][Full Text] [Related]
3. Disparities in hemodynamic resuscitation of the obese critically ill septic shock patient.
Adams C; Tucker C; Allen B; McRae A; Balazh J; Horst S; Johnson D; Ferreira J
J Crit Care; 2017 Feb; 37():219-223. PubMed ID: 27969574
[TBL] [Abstract][Full Text] [Related]
4. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of obesity on safety and efficacy of weight-based norepinephrine dosing in septic shock: A single-center, retrospective study.
Wong PJ; Pandya KA; Flannery AH
Intensive Crit Care Nurs; 2017 Aug; 41():104-108. PubMed ID: 28343834
[TBL] [Abstract][Full Text] [Related]
6. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
Miller JT; Welage LS; Kraft MD; Alaniz C
J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
[TBL] [Abstract][Full Text] [Related]
7. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
Droege CA; Ernst NE
Ann Pharmacother; 2017 Jul; 51(7):614-616. PubMed ID: 28205455
[TBL] [Abstract][Full Text] [Related]
8. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.
Kim WY; Jun JH; Huh JW; Hong SB; Lim CM; Koh Y
Shock; 2013 Dec; 40(6):527-31. PubMed ID: 24089010
[TBL] [Abstract][Full Text] [Related]
9. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
[TBL] [Abstract][Full Text] [Related]
10. A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study.
Xu JY; Ma SQ; Pan C; He HL; Cai SX; Hu SL; Liu AR; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
Crit Care; 2015 Mar; 19(1):130. PubMed ID: 25887027
[TBL] [Abstract][Full Text] [Related]
11. Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock.
Lenney M; Kopp B; Erstad B
Am J Health Syst Pharm; 2022 Aug; 79(Suppl 3):S94-S99. PubMed ID: 35670445
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
13. Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock.
Guinot PG; Bernard E; Levrard M; Dupont H; Lorne E
Crit Care; 2015 Jan; 19(1):14. PubMed ID: 25598221
[TBL] [Abstract][Full Text] [Related]
14. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
[TBL] [Abstract][Full Text] [Related]
15. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
16. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.
Hammond DA; Ficek OA; Painter JT; McCain K; Cullen J; Brotherton AL; Kakkera K; Chopra D; Meena N
Pharmacotherapy; 2018 May; 38(5):531-538. PubMed ID: 29600824
[TBL] [Abstract][Full Text] [Related]
17. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
Seguin P; Bellissant E; Le Tulzo Y; Laviolle B; Lessard Y; Thomas R; Mallédant Y
Clin Pharmacol Ther; 2002 May; 71(5):381-8. PubMed ID: 12011824
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
[TBL] [Abstract][Full Text] [Related]
19. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
20. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
